Suppr超能文献

阿片肽:一种用于早期检测2型糖尿病患者糖尿病肾病的潜在新型血清生物标志物。

Apelin: A potential novel serum biomarker for early detection of diabetic nephropathy in patients with type 2 diabetes.

作者信息

Demirpence Mustafa, Yilmaz Hamiyet, Colak Ayfer, Pamuk Baris Onder, Karakoyun Inanc, Basok Banu

机构信息

Department of Endocrinology and Metabolism, Tepecik Training and Research Hospital, Izmir, Turkey.

Department of Clinical Biochemistry, Tepecik Training and Research Hospital, Izmir, Turkey.

出版信息

North Clin Istanb. 2018 Aug 14;6(2):151-155. doi: 10.14744/nci.2018.62134. eCollection 2019.

Abstract

OBJECTIVE

Diabetic nephropathy (DN) is the major cause of chronic renal failure, and proteinuria is an independent risk factor for the end stage renal disease. The random urine protein: creatinine ratio (P:C ratio) can accurately predict the amount of 24-hour urinary protein excretion. Apelin is thought to be associated with endothelial dysfunction, angiogenesis, and inflammation. This study investigated the apelin concentration and its association with the urine P:C ratio, and metabolic parameters in subjects with and without type 2 diabetes mellitus (T2D).

METHODS

This study involved 86 subjects: 56 with newly diagnosed and untreated T2D and 30 non-diabetic controls. All subjects underwent a complete clinical examination that included anthropometric and laboratory measurements.

RESULTS

Twenty-four males and sixty-two females participated in this study, and their mean age was 52.27±11.34 years. There were no differences in age, thyrotropin-stimulating hormone (TSH), creatinine clearance, and apelin levels between groups. As expected, fasting plasma glucose, weight, body mass index, and HbA1C were higher in T2D subjects (p=0.001, p=0.02, p=0.03, and p=0.001, respectively). Although apelin levels were higher in the control group, the differences were not statistically significant (p=0.93). The P:C ratio levels were lower in the control group, and the differences were statistically significant (p=0.006). A Spearman correlation analysis revealed that serum apelin levels were not correlated with the urine P:C ratio.

CONCLUSION

Our study demonstrates that T2D is associated with decreased serum apelin levels and increased urine P:C ratios compared to those in non-diabetic subjects. This association may depend on impaired glucose homeostasis. Our results show that the serum apelin levels were not correlated with the urine protein: creatinine ratio and provide further evidence regarding the relationship between apelin and DN.

摘要

目的

糖尿病肾病(DN)是慢性肾衰竭的主要病因,蛋白尿是终末期肾病的独立危险因素。随机尿蛋白与肌酐比值(P:C比值)可准确预测24小时尿蛋白排泄量。阿片肽被认为与内皮功能障碍、血管生成和炎症有关。本研究调查了2型糖尿病(T2D)患者和非T2D患者的阿片肽浓度及其与尿P:C比值和代谢参数的关系。

方法

本研究纳入86名受试者:56名新诊断且未接受治疗的T2D患者和30名非糖尿病对照者。所有受试者均接受了包括人体测量和实验室检测在内的全面临床检查。

结果

24名男性和62名女性参与了本研究,他们的平均年龄为52.27±11.34岁。两组之间在年龄、促甲状腺激素(TSH)、肌酐清除率和阿片肽水平方面无差异。正如预期的那样,T2D患者的空腹血糖、体重、体重指数和糖化血红蛋白水平更高(分别为p = 0.001、p = 0.02、p = 0.03和p = 0.001)。虽然对照组的阿片肽水平较高,但差异无统计学意义(p = 0.93)。对照组的P:C比值水平较低,差异有统计学意义(p = 0.006)。Spearman相关性分析显示,血清阿片肽水平与尿P:C比值无相关性。

结论

我们的研究表明,与非糖尿病受试者相比,T2D与血清阿片肽水平降低和尿P:C比值升高有关。这种关联可能取决于葡萄糖稳态受损。我们的结果表明,血清阿片肽水平与尿蛋白与肌酐比值无相关性,并为阿片肽与DN之间的关系提供了进一步的证据。

相似文献

1
Apelin: A potential novel serum biomarker for early detection of diabetic nephropathy in patients with type 2 diabetes.
North Clin Istanb. 2018 Aug 14;6(2):151-155. doi: 10.14744/nci.2018.62134. eCollection 2019.
2
Altered glucose homeostasis is associated with increased serum apelin levels in type 2 diabetes mellitus.
PLoS One. 2012;7(12):e51236. doi: 10.1371/journal.pone.0051236. Epub 2012 Dec 5.
3
Connection between the Plasma Level of Apelin and Diabetic Nephropathy in Type 2 Diabetic Patients. A Case Control Study.
Indian J Endocrinol Metab. 2021 Sep-Oct;25(5):418-426. doi: 10.4103/ijem.ijem_300_21. Epub 2022 Jan 12.
4
Evaluation of the relationship between serum apelin levels and vitamin D and mean platelet volume in diabetic patients.
Ann Endocrinol (Paris). 2014 Sep;75(4):200-5. doi: 10.1016/j.ando.2014.07.112. Epub 2014 Aug 23.
5
An evaluation of both serum Klotho/FGF-23 and apelin-13 for detection of diabetic nephropathy.
Hormones (Athens). 2023 Sep;22(3):413-423. doi: 10.1007/s42000-023-00464-4. Epub 2023 Jul 17.
6
Elevation of serum apelin-13 associated with proliferative diabetic retinopathy in type 2 diabetic patients.
Int J Ophthalmol. 2014 Dec 18;7(6):968-73. doi: 10.3980/j.issn.2222-3959.2014.06.10. eCollection 2014.
7
Apelin, Nitric Oxide and Vascular Affection in Adolescent Type 1 Diabetic Patients.
Open Access Maced J Med Sci. 2017 Dec 4;5(7):934-939. doi: 10.3889/oamjms.2017.204. eCollection 2017 Dec 15.
8
Evaluation of Apelin-13 levels in patients with diabetic nephropathy.
Int Urol Nephrol. 2023 Feb;55(2):345-353. doi: 10.1007/s11255-022-03323-0. Epub 2022 Aug 4.
9
Evaluation of serum Spondin 2 levels in the different stages of Type 2 diabetic nephropathy.
Nephrology (Carlton). 2015 Oct;20(10):721-726. doi: 10.1111/nep.12507.
10
Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
J Bras Nefrol. 2019 Oct-Dec;41(4):509-517. doi: 10.1590/2175-8239-JBN-2018-0200.

引用本文的文献

4
Expression of apelin‑13 and its negative correlation with TGF‑β1 in patients with diabetic kidney disease.
Exp Ther Med. 2024 Jan 23;27(3):110. doi: 10.3892/etm.2024.12398. eCollection 2024 Mar.
5
An evaluation of both serum Klotho/FGF-23 and apelin-13 for detection of diabetic nephropathy.
Hormones (Athens). 2023 Sep;22(3):413-423. doi: 10.1007/s42000-023-00464-4. Epub 2023 Jul 17.
7
Low serum apelin levels are associated with mild cognitive impairment in Type 2 diabetic patients.
BMC Endocr Disord. 2022 May 24;22(1):137. doi: 10.1186/s12902-022-01051-1.
8
The Role of Apelin-APJ System in Diabetes and Obesity.
Front Endocrinol (Lausanne). 2022 Mar 9;13:820002. doi: 10.3389/fendo.2022.820002. eCollection 2022.
9
Connection between the Plasma Level of Apelin and Diabetic Nephropathy in Type 2 Diabetic Patients. A Case Control Study.
Indian J Endocrinol Metab. 2021 Sep-Oct;25(5):418-426. doi: 10.4103/ijem.ijem_300_21. Epub 2022 Jan 12.
10
The role of Elabela in kidney disease.
Int Urol Nephrol. 2021 Sep;53(9):1851-1857. doi: 10.1007/s11255-021-02790-1. Epub 2021 Mar 8.

本文引用的文献

1
Apelin/APJ system as a therapeutic target in diabetes and its complications.
Mol Genet Metab. 2016 Sep;119(1-2):20-7. doi: 10.1016/j.ymgme.2016.07.012. Epub 2016 Jul 28.
2
Serum apelin and ADMA levels in type 2 diabetics with and without vascular complications.
Diabetes Metab Syndr. 2016 Apr-Jun;10(2 Suppl 1):S106-9. doi: 10.1016/j.dsx.2016.03.005. Epub 2016 Mar 14.
3
Circulating apelin is increased in patients with type 1 or type 2 diabetes and is associated with better glycaemic control.
Clin Endocrinol (Oxf). 2014 Nov;81(5):696-701. doi: 10.1111/cen.12404. Epub 2014 Feb 4.
4
Promoting effects of the adipokine, apelin, on diabetic nephropathy.
PLoS One. 2013;8(4):e60457. doi: 10.1371/journal.pone.0060457. Epub 2013 Apr 5.
5
Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy.
Biochem Biophys Res Commun. 2013 Apr 19;433(4):359-61. doi: 10.1016/j.bbrc.2013.02.120. Epub 2013 Mar 26.
6
Apelin retards the progression of diabetic nephropathy.
Am J Physiol Renal Physiol. 2013 Mar 15;304(6):F788-800. doi: 10.1152/ajprenal.00306.2012. Epub 2013 Jan 9.
7
Altered glucose homeostasis is associated with increased serum apelin levels in type 2 diabetes mellitus.
PLoS One. 2012;7(12):e51236. doi: 10.1371/journal.pone.0051236. Epub 2012 Dec 5.
10
Medical care costs associated with progression of diabetic nephropathy.
Diabetes Care. 2011 Nov;34(11):2374-8. doi: 10.2337/dc11-0475.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验